10x Genomics Files 8-K Report
Ticker: TXG · Form: 8-K · Filed: May 14, 2025 · CIK: 1770787
| Field | Detail |
|---|---|
| Company | 10x Genomics, Inc. (TXG) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
10x Genomics filed an 8-K on 5/14 for events on 5/12, confirming HQ address.
AI Summary
On May 12, 2025, 10x Genomics, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 6230 Stoneridge Mall Road, Pleasanton, California, 94588. The report was filed on May 14, 2025, and pertains to events reported as of May 12, 2025.
Why It Matters
This filing provides an update on the company's official reporting and corporate information, which is standard for public companies and relevant for investors tracking corporate actions.
Risk Assessment
Risk Level: low — This is a routine corporate filing that does not disclose new material financial or operational information.
Key Players & Entities
- 10x Genomics, Inc. (company) — Registrant
- May 12, 2025 (date) — Date of earliest event reported
- May 14, 2025 (date) — Filing date
- 6230 Stoneridge Mall Road, Pleasanton, California, 94588 (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for 10x Genomics, Inc., indicating events that occurred or were reported as of May 12, 2025.
When was this 8-K report filed with the SEC?
The 8-K report was filed on May 14, 2025.
What is the principal executive office address for 10x Genomics, Inc. as stated in the filing?
The principal executive offices are located at 6230 Stoneridge Mall Road, Pleasanton, California, 94588.
What is the Commission File Number for 10x Genomics, Inc.?
The Commission File Number for 10x Genomics, Inc. is 001-39035.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding 10x Genomics, Inc. (TXG).